Mae’n dda gennyf roi gwybod i’r aelodau bod Gweinidogion Iechyd heddiw wedi cymeradwyo codi’r gwaharddiad presennol ar ffracsiynu plasma’r DU ar gyfer ei ddefnyddio mewn cynnyrch meddyginiaethol sy’n deillio o blasma, yn sgil yr adolygiad gan yr Asiantaeth Rheoleiddio Meddyginiaethau a Chynhyrchion Gofal Iechyd, a’r cyngor dilynol gan y Comisiwn Meddyginiaethau Dynol.
I am pleased to inform members that today following a review by the Medicines and Healthcare products Regulatory Agency (MHRA), and subsequent advice from the Commission on Human Medicines (CHM) UK Health Ministers have given approval to lift the current ban on the fractionation of UK plasma for the use in plasma derived medicinal products (PDMP).